跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,527 条关于
“Trk-PAM”
全部
4,527
临床试验
3,260
药物
801
机构
106
资讯
360
去年
AlzeCure's ACD856 Shows Promise with Anti-Inflammatory Effects in Alzheimer's Models
去年
AlzeCure's ACD856 Alzheimer's Drug Receives EU Funding for Phase 2 Trial
9个月前
AlzeCure Receives €2.5 Million EU Grant to Advance Phase 2a Trial of Novel Alzheimer's Drug ACD856
去年
Next-Generation TRK Inhibitors Show Promise in Treating NTRK Fusion-Positive Cancers
3个月前
Vcare PharmaTech's Next-Generation TRK Inhibitor Eratrectinib Wins NMPA Approval for NTRK Fusion-Positive Solid Tumors
9个月前
InnoCare's Next-Generation TRK Inhibitor Zurletrectinib Receives NMPA Approval in China for NTRK Fusion-Positive Solid Tumors
5个月前
Addex GABAB PAM Candidate Shows Promising Anti-Cough Activity in Non-Human Primate Studies
去年
Disitamab Vedotin Shows Promising Activity in HER2-Expressing Metastatic Breast Cancer with PAM Pathway Abnormalities
去年
Larotrectinib Shows High Efficacy in Pediatric Solid Tumors with NTRK Fusion
2年前
Error parsing response
第 1 页,共 36 页
上一页
下一页